Pregled bibliografske jedinice broj: 879306
Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)- PIM list, STOPP version 2 criteria and comprehensive protocol.
Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)- PIM list, STOPP version 2 criteria and comprehensive protocol. // European journal of clinical pharmacology, 73 (2017), 8; 991-999 doi:10.1007/s00228-017-2246-y (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 879306 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)- PIM list, STOPP version 2 criteria and comprehensive protocol.
Autori
Mucalo, Iva ; Ortner Hadžiabdić, Maja ; Brajković, Andrea ; Lukić, Sonja ; Marić, Patricia ; Marinović, Ivana ; Bačić-Vrca, Vesna
Izvornik
European journal of clinical pharmacology (0031-6970) 73
(2017), 8;
991-999
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Comprehensive protocol ; EU(7)-PIM list ; Polypharmacy ; Potentially inappropriate medicines ; STOPP version 2 criteria
Sažetak
The aim of this study was to measure the prevalence of potentially inappropriate medications (PIMs) by using the EU(7)-PIM list, STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions) version 2 criteria and the new comprehensive protocol. This prospective study involved a sample of 276 consecutive elderly patients discharged from the university teaching hospital. Age, gender, diagnoses, medication history and medicines at discharge were recorded. The main outcome measure was the prevalence of PIMs according to each set of criteria: EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. The median patient age (range) was 74 (65-92) years. The median number of prescribed medications was 7 (1-17). STOPP identified 393 PIMs affecting 190 patients (69%), EU(7)-PIM list identified 330 PIMs in 184 patients (66.7%) whilst the comprehensive protocol identified 134 PIMs in 102 patients (37%). STOPP version 2 criteria identified significantly more PIMs per patient than the other two protocols (p < 0.001). Gender (p = 0.002), glomerular filtration rate (p = 0.039) and number of comorbidities (p = 0.001) were associated with the proportion of PIMs for the STOPP version 2 criteria only. A very high PIM prevalence at discharge was reported suggesting the urgent need for actions to reduce them. STOPP version 2 criteria identified significantly more PIMs than the EU(7)-PIM list and the comprehensive protocol and was found as a more sensitive tool for PIM detection.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Profili:
Maja Ortner Hadžiabdić
(autor)
Andrea Brajković
(autor)
Iva Mucalo
(autor)
Ivana Marinović
(autor)
Vesna Bačić Vrca
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE